Novel prophylactic and therapeutic vaccine against tuberculosis
Masaji Okada(NHO Kinki Chuo Chest Medical Center), Mitsunori Sakatani(NHO Kinki Chuo Chest Medical Center), Noriko Kanamaru(NHO Kinki Chuo Chest Medical Center), T Nagasawa, Yoko Kita(NHO Kinki Chuo Chest Medical Center), Esterlina V. Tan, Chie Kishigami(NHO Kinki Chuo Chest Medical Center), Paul Saunderson(Veolia (United Kingdom)), Shigeto Yoshida(Jichi Medical University), Eduardo Canteiro Cruz, Yasuko Nishida(NHO Kinki Chuo Chest Medical Center), Rodolfo M. Abalos, Yasufumi Kaneda(Osaka University), Hitoshi Nakatani(NHO Kinki Chuo Chest Medical Center), Toshihiro Nakajima(St. Marianna University School of Medicine), Kyoko Takao(NHO Kinki Chuo Chest Medical Center), Makoto Matsumoto(Tottori University Hospital), Satomi Hashimoto(NHO Kinki Chuo Chest Medical Center), Yoshikazu Inoue(Fukujuji Hospital), David N. McMurray(Texas A&M Health Science Center), Jasmin Burgos
Cited by 38
Related Papers
A Toll-like receptor recognizes bacterial DNA
|Nature|2000|6.4k
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
|The Lancet|1986|2.4k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k